CAMBRIDGE, Mass. & SALISBURY, England–(BUSINESS WIRE)—- $KALV–KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhib…
Author: Business Wire
NovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Low Share Price
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that on October 3, 2022 it received a notice from the NYSE American LLC that the Company’s common stock has been selling for a low price per share for a …
Global Contact Lenses Market Report (2022 to 2027) – Industry Trends, Share, Size, Growth, Opportunity and Forecasts – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Contact Lenses Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering. The global contact lenses market size reached US$ 7.6 Bill…
Global Ophthalmology Devices Market to Grow by $17.09 Billion During 2022-2026 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Ophthalmology Devices Market 2022-2026” report has been added to ResearchAndMarkets.com’s offering. The ophthalmology devices market is poised to grow by $17.09 bn during 2022-2026, accelerating at a CAGR of 4.1% du…
UAE Eye Care Market Report 2022: Continuous R&D Activities to Open New Avenues For Growth – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “UAE Eye Care Market, By Product Type (Eyeglasses, Contact Lens, Intraocular Lens, Eye Drops, Eye Vitamins, Others), By Coating (Anti-Glare, UV, Others), By Lens Material, By Distribution Channel, By Region, Competition For…
Diabetic Eye Disease Devices Global Market to Grow by 7.64% Annually Through 2029 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Diabetic Eye Disease Devices Market Analysis, by Disease, by Devices, by End-User, and by Region – Global Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering. The diabetic eye disease devices marke…
U.S.Vision Announces Hurricane Relief at Local JCPenney Optical Stores
BLACKWOOD, N.J.–(BUSINESS WIRE)–U.S.Vision has announced a temporary program to help Florida residents in the wake of Hurricane Ian’s destruction in that state’s southwest region.
Palm Medical Announces the Opening of New Senior Primary Care Center in Aventura
CORAL GABLES, Fla.–(BUSINESS WIRE)–Palm Medical announces the opening of its 24th senior primary care clinic in Aventura, Florida.
VECT-HORUS RECOIT UNE SUBVENTION POUR LE DEVELOPPEMENT DE SA PLATEFORME VECTRANS® DANS LE DOMAINE DE L’OPHTALMOLOGIE
MARSEILLE, France–(BUSINESS WIRE)–Vect-Horus, une société de biotechnologie qui conçoit et développe des vecteurs permettant l’adressage ciblé de molécules thérapeutiques et d’agents d’imagerie vers différents organes dont le cerveau, annonce l’accor…
Santen Announces Health Canada Approval for Cationorm® Plus to Relieve the Symptoms of Dry Eye and Ocular Allergy
TORONTO–(BUSINESS WIRE)–Santen Canada Inc., a subsidiary of Santen Pharmaceutical Co., Ltd. (Santen), today announced the approval of Cationorm® Plus by Health Canada. Cationorm® Plus is a unique hydrating artificial tear that restores moisture in th…
Santen annonce l’approbation de CationormMD Plus pour soulager les symptômes de la sécheresse et l’allergie oculaires
TORONTO–(BUSINESS WIRE)–Santen Canada Inc., filiale de Santen Pharmaceutical Co., Ltd. (« Santen »), a annoncé aujourd’hui l’approbation de CationormMD Plus par Santé Canada. CationormMD Plus est une solution unique de larmes artificielles qui restau…
Aldeyra Therapeutics Achieves Primary Endpoint in Part 1 of Phase 3 GUARD Trial of ADX-2191 in Proliferative Vitreoretinopathy
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra or the Company) today announced the achievement of the primary endpoint in Part 1 of the Phase 3 GUARD Trial of ADX-2191 (methotrexate injection, USP1) for intravitre…
Insights on the Intraocular Lens Global Market to 2030 – Featuring Alcon, Carl Zeiss Meditec, HOYA and Lenstec Among Others – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Intraocular Lens Market, by Product Type, by Flexibility, by Material, by End-user, and by Region – Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030” report has been added to ResearchAndMarkets.com’s offering. A…
Topcon Introduces NW500 Non-Mydriatic Retinal Camera
TOKYO–(BUSINESS WIRE)– #TopconHealthcare–Topcon Healthcare, a leading provider of medical devices and software solutions for the global eye care community, is pleased to announce that it has launched the NW500, its new fully-automatic, non-mydriatic…
Harrow Sells Non-Ophthalmic Compounding Business
NASHVILLE, Tenn.–(BUSINESS WIRE)—- $HROW–Harrow (Nasdaq: HROW), an eyecare pharmaceutical company exclusively focused on the discovery, development, and commercialization of innovative ophthalmic therapies, today announced the sale of its non‑ophth…
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass. & SALISBURY, England–(BUSINESS WIRE)–KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that the compensation committee of KalVista’s board of directors granted four newly-hired employees inducement options to purchase an…
Global Eye Surgical Market Research and Forecast 2022-2028: Increasing Prevalence of Eye-Related Diseases Driving Growth – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Eye Surgical Market Research and Forecast 2022-2028” report has been added to ResearchAndMarkets.com’s offering. The global eye surgical market is anticipated to grow at a substantial CAGR during the forecast period…
Zenni Surpasses 50 Million Pairs of Glasses Sold, New Mobile App Release Accelerates Growth for Online Eyewear Retail Pioneer
NOVATO, Calif.–(BUSINESS WIRE)–Zenni, the online eyewear retail leader, announced today it has recently eclipsed 50 million pairs of glasses sold since its launch in 2003, signaling its continued growth and ability to scale in a competitive market la…
Kubota Vision Announces Positive Post Hoc Analysis from Phase 3 Clinical Trial of Emixustat in Patients with Stargardt Disease
SEATTLE–(BUSINESS WIRE)–Kubota Vision Inc. (“Kubota Vision”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), announced today positive results from a post hoc analysis of th…
Global Dry Eye Syndrome Therapeutics Market Report to 2029 – Featuring Abbott, AbbVie, Allergan and AstraZeneca Among Others – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Dry Eye Syndrome Therapeutics Market Analysis by Product Type, by Disease Type, and by Region – Global Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering. The dry eye syndrome (DES) therapeutics m…